RING THERAPEUTICS
Live / Registered — Registered (as of 28 May 2024)
What this means for you
Registered since 28 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97462190
- Registration number
- 7402892
- Mark type
- Stylized text
- Filed
- 16 Jun 2022
- Published for opposition
- 10 Jan 2023
- Registered
- 28 May 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 28 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Mar 2024 — USE AMENDMENT FILED
- 29 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 26 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Nov 2023 — ASSIGNED TO EXAMINER
- 31 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Aug 2023 — SOU EXTENSION 1 GRANTED
- 29 Aug 2023 — SOU EXTENSION 1 FILED